Innovations in post-diagnosis support

Описание: Following the launch of the World Alzheimer Report 2022, this webinar 'Innovations in post-diagnosis support: The changing role of clinicians, treatments and care interventions', centres on recent and future innovations taking place in post-diagnosis treatment, including both pharmacological and non-pharmacological treatments, as well as care and support.

During this 75-minute event, the co-lead authors and a panel of expert speakers highlighted some of the report’s key findings and recommendations from the World Alzheimer Report, and asked how these innovations may radically change and improve the post-diagnostic treatment landscape, both now and in the future.

00:00:00 ADI CEO Paola Barbarino introduces ADI, the webinar panellists and the pertinent findings and recommendations from the World Alzheimer Report 2022.
00:08:30 World Alzheimer Report 2022 co-author Professor Pedro Rosa-Neto of McGill University provides an overview of the relevant content of the report, the staging of dementia, multidomain interventions including risk reduction, disease-modifying therapies and personalised care.
00:15:44 World Alzheimer Report 2022 co-author Professor José Morais focuses on the content of the report relating to support in a primary care setting, the importance of care planning, empowering informal carers and the need for greater education for health care professionals.
00:26:05 Former CEO of Alzheimer Switzerland, Birgitta Martensson speaks from the perspective of a person living with Alzheimer’s on the need for a person living with dementia to be at centre of the decision making process relating to their own care, and the importance of timely diagnosis.
00:32:42 Associate VP, International Medical Affairs, Eli Lilly and Company, Dr Grazia Dell'Agnello discussed the evolving care pathway for people living with dementia in light of emerging therapies, including the need for accurate diagnoses using biomarkers and personalised disease modifying treatments.
00:43:14 Executive Director, External Stakeholder Engagement, Global Medial Affairs, Alzheimer's disease Brain Health at Eisai Inc, Dr Susan Dr Santi, highlights the changing therapeutic, diagnostic and monitoring landscape for Alzheimer's disease and the need to change current care paradigms to accommodate them.
00:50:31 Dr Yuda Turana, School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia concludes the series of talks by discussing the results of the World Alzheimer Report and post-diagnostic innovations from the context of low- and middle-income counties.
00:55:02 Q&A discussion with the panelists

Read the World Alzheimer Report 2022: http://bit.ly/WorldAlzReport2022

Make a difference by donating https://www.alzint.org/donate

Find more information on our website https://www.alzint.org/

Sign up to our email list https://www.alzint.org/newsletter

Follow us
Twitter   / alzdisint  
Facebook   / alzdisint  
Instagram   / alzdisint  
LinkedIn   / alzdisint